Market Overview

Lazard Global Total Return and Income Fund Declares Monthly Distribution

Share:

The Board of Directors of Lazard Global Total Return and Income Fund,
Inc. (the "Fund") (NYSE:LGI) has authorized the Fund to declare
today, pursuant to a level distribution policy, a monthly distribution
of $0.11556 per share on the Fund's outstanding common stock. The
distribution is payable on October 23, 2018 to shareholders of record on
October 12, 2018. The ex-dividend date is October 11, 2018.

Portfolio data as of August 31, 2018, including performance, asset
allocation, top 10 holdings, sector weightings, regional exposure, and
other Fund characteristics have been posted on Lazard Asset Management's
("LAM") website, www.LazardAssetManagement.com.
Additionally, any notices required by Section 19(a) of the Investment
Company Act of 1940, as amended, which provide information regarding the
respective estimated amounts of each monthly distribution derived from
net investment income, net realized capital gains (short- and long-term)
and return of capital, will also be available on www.LazardAssetManagement.com.

The Fund's objective is total return consisting of capital appreciation
and current income. The Fund invests in a portfolio of approximately 60
to 80 US and non-US equity securities, including American Depository
Receipts. The Fund generally invests in securities of companies with
market capitalizations greater than $2 billion and may invest in
emerging markets. The Fund seeks enhanced income by investing in short
duration (typically less than one year) emerging market forward currency
contracts and other emerging market debt instruments.

An indirect subsidiary of Lazard Ltd (NYSE:LAZ), LAM, the Fund's
investment manager, offers a range of equity, fixed-income, and
alternative investment products worldwide. As of June 30, 2018, LAM and
affiliated asset management companies in the Lazard Group managed $238
billion worth of client assets. For more information about LAM, please
go to www.LazardAssetManagement.com.

View Comments and Join the Discussion!